Company Filing History:
Years Active: 2016-2018
Title: Rajkumar Hangarge: Innovator in Pharmaceutical Compounds
Introduction
Rajkumar Hangarge is a notable inventor based in Pune, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of MEK inhibitors. With a total of five patents to his name, his work is recognized for its potential impact on therapeutic treatments.
Latest Patents
Rajkumar's latest patents focus on heterocyclyl compounds as MEK inhibitors. The first patent discloses heteroaryl compounds of formula I, which include their pharmaceutically acceptable salts and combinations with suitable medicaments. This patent also outlines the processes for preparing these compounds and their applications in treatment methods. The second patent similarly addresses heteroaryl compounds as MEK inhibitors, detailing their tautomers and acceptable salts, along with the intended therapeutic uses.
Career Highlights
Rajkumar Hangarge is currently associated with Lupin, Inc., a prominent player in the pharmaceutical industry. His work at Lupin has allowed him to explore innovative solutions in drug development, particularly in the area of cancer treatment.
Collaborations
Some of Rajkumar's coworkers include Bhavesh Dave and Rakesh Kumar Banerjee. Their collaborative efforts contribute to the advancement of pharmaceutical research and development within their organization.
Conclusion
Rajkumar Hangarge stands out as an influential inventor in the pharmaceutical sector, with a focus on developing innovative MEK inhibitors. His contributions are paving the way for new therapeutic options in medicine.